picolinic acid has been researched along with Insulin Sensitivity in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 17 (56.67) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Khare, S; Kumar, A; Kumar, M; Kumar, V; Kushwaha, R; Shukla, PK; Singh, SK; Singh, Y; Vaswani, S; Yadav, RS | 1 |
| Bazyar, H; Khoshbaten, M; Kooshki, F; Moradi, F; Nokhostin, F; Pourghassem Gargari, B | 1 |
| Asemi, Z; Jamilian, M | 1 |
| Abou-Gamrah, A; Ashoush, S; Bayoumy, H; Othman, N | 1 |
| Breithaupt, L; Brownley, KA; Bulik, CM; Hamer, RM; La Via, MC; Sala, M | 1 |
| Elmendorf, JS; Horvath, EM; Tackett, L | 1 |
| Wang, YQ; Yao, MH | 1 |
| Dong, Y; Wang, YQ; Yao, MH | 1 |
| Anderson, RA; Cefalu, WT; Levitan, L; Martin, CK; Martin, JM; Newcomer, B; Pinsonat, P; Qin, J; Rood, J; Sereda, O; Wang, ZQ; Zhang, XH | 1 |
| Aghdassi, E; Allard, JP; Arendt, BM; Bondar, H; Jalali, P; Mohammed, SS; Salit, IE | 1 |
| Abdelsayed, R; El-Marakby, A; El-Salanty, M; Liu, JY; Mozaffari, MS; Wimborne, H; Zakhary, I | 1 |
| Power, M; Pratley, R | 1 |
| Aiyun, H; Jiajun, Y; Minhong, Z; Shanshan, Z | 1 |
| Kang, JS; Kim, DS; Kim, TW | 1 |
| Dhalla, NS; Goyal, RK; Sharma, G; Shindea, UA; Xu, YJ | 1 |
| Ravina, A | 1 |
| McCarty, MF | 4 |
| Docherty, JP; Finch, M; Komorowski, JR; Roffman, M; Sack, DA | 1 |
| Brzyski, RG; Easton, CA; Holden, AE; Lucidi, RS; Schenken, RS; Thyer, AC | 1 |
| Cefalu, WT; Hulver, M; Russell, JC; Wang, ZQ; Zhang, XH | 1 |
| Bembo, S; Gelato, M; Komaroff, E; Lydic, ML; McNurlan, M; Mitchell, L | 1 |
| Ellwood, KC; Trumbo, PR | 1 |
| Havel, PJ; Kelly, SE; Proctor, SD; Russell, JC; Stanhope, KL | 1 |
| Brozinick, JT; Elmendorf, JS; Horvath, EM; McCarthy, AM; Raman, P; Tackett, L | 1 |
| Feiner, JJ; Ferris, RE; Gelato, MC; McNurlan, MA; Mynarcik, DC | 1 |
| Kang, JS; Kim, DS; Kim, TW; Om, AS; Park, IK | 1 |
| Baldor, LC; Cefalu, WT; Russell, JC; Wang, ZQ; Zhang, XH | 1 |
2 review(s) available for picolinic acid and Insulin Sensitivity
| Article | Year |
|---|---|
Alternative and complementary treatments for metabolic syndrome.
Topics: Animals; Cinnamomum zeylanicum; Humans; Insulin Resistance; Metabolic Syndrome; Picolinic Acids; Plant Extracts | 2011 |
Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dietary Supplements; Evidence-Based Medicine; Food Labeling; Humans; Insulin Resistance; Picolinic Acids; Risk Factors; United States; United States Food and Drug Administration | 2006 |
10 trial(s) available for picolinic acid and Insulin Sensitivity
| Article | Year |
|---|---|
A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
Topics: Adult; alpha-2-HS-Glycoprotein; Biomarkers; C-Reactive Protein; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin Resistance; Interleukin-6; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Picolinic Acids; Pilot Projects; Tumor Necrosis Factor-alpha; Young Adult | 2021 |
Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Cholesterol; Cholesterol, VLDL; Dietary Supplements; Double-Blind Method; Fasting; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Iron Chelating Agents; Picolinic Acids; Polycystic Ovary Syndrome; Prospective Studies; Triglycerides; Young Adult | 2015 |
Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
Topics: Adult; Dietary Supplements; Female; Humans; Insulin Resistance; Outcome Assessment, Health Care; Picolinic Acids; Polycystic Ovary Syndrome; Young Adult | 2016 |
A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.
Topics: Adult; Binge-Eating Disorder; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Overweight; Picolinic Acids; Pilot Projects; Time Factors | 2017 |
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Composition; Body Weight; Cohort Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Least-Squares Analysis; Liver; Male; Middle Aged; Muscle, Skeletal; Picolinic Acids; Young Adult | 2010 |
In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial.
Topics: Blood Chemical Analysis; Body Composition; Body Weight; Diet; Dietary Supplements; Female; HIV; HIV Infections; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Picolinic Acids; Treatment Outcome | 2010 |
A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
Topics: Adult; Appetite; Depressive Disorder; Dietary Carbohydrates; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Iron Chelating Agents; Male; Middle Aged; Picolinic Acids; Placebos; Treatment Outcome | 2005 |
Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Female; Glucose Intolerance; Humans; Insulin Resistance; Iron Chelating Agents; Menstrual Cycle; Ovary; Ovulation; Picolinic Acids; Pilot Projects; Polycystic Ovary Syndrome | 2005 |
Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome.
Topics: Adult; Female; Humans; Hyperinsulinism; Insulin Resistance; Iron Chelating Agents; Obesity; Picolinic Acids; Polycystic Ovary Syndrome; Treatment Outcome | 2006 |
Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Female; Glucose Clamp Technique; HIV Infections; Humans; Insulin Resistance; Iron Chelating Agents; Male; Middle Aged; Picolinic Acids; Pilot Projects; Treatment Outcome | 2008 |
18 other study(ies) available for picolinic acid and Insulin Sensitivity
| Article | Year |
|---|---|
Dietary Chromium Picolinate Supplementation Improves Glucose Utilization in Transition Calf by Ameliorating Insulin Response.
Topics: Animal Feed; Animals; Blood Glucose; Cattle; Chromium; Diet; Dietary Supplements; Fatty Acids, Nonesterified; Glucose; Insulin; Insulin Resistance | 2023 |
A novel membrane-based anti-diabetic action of atorvastatin.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Atorvastatin; Cell Membrane; Cholesterol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Resistance; Mice; Picolinic Acids; Pyrroles | 2008 |
Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Chromium; Enzyme Activation; Glucose; Glucose Transporter Type 4; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Resistance; Mice; p38 Mitogen-Activated Protein Kinases; Picolinic Acids; Protein Transport; Pyridines; Signal Transduction | 2009 |
Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of amp-activated protein kinase.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Hypoglycemic Agents; Immunoblotting; Insulin Resistance; Mice; Picolinic Acids; Resistin; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Submandibular gland and caries susceptibility in the obese Zucker rat.
Topics: Animals; Dental Caries; Dental Caries Susceptibility; Dietary Supplements; Inflammation Mediators; Insulin Resistance; Male; NF-kappa B; Obesity; Picolinic Acids; Rats; Rats, Zucker; Sialadenitis; Submandibular Gland | 2011 |
Regulation of organic nucleic acids and serum biochemistry parameters by dietary chromium picolinate supplementation in swine model.
Topics: Animals; Blood; Blood Glucose; Dietary Supplements; Humans; Insulin; Insulin Resistance; Iron Chelating Agents; Male; Muscles; Nucleic Acids; Pancreas; Picolinic Acids; Random Allocation; Receptor, Insulin; Swine | 2011 |
Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Supplements; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Iron Chelating Agents; Male; Picolinic Acids; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley | 2004 |
Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus.
Topics: 3T3 Cells; Animals; Animals, Newborn; Area Under Curve; Cell Differentiation; Cholesterol; Chromium; Diabetes Mellitus, Experimental; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Iron Chelating Agents; Male; Mice; Myoblasts; Picolinic Acids; Random Allocation; Rats; Rats, Wistar; Triglycerides | 2004 |
Initiating insulin in type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Picolinic Acids | 2004 |
Chromium picolinate may favorably influence the vascular risk associated with smoking by combating cortisol-induced insulin resistance.
Topics: Adrenocorticotropic Hormone; Animals; Cardiovascular Diseases; Dexamethasone; Dietary Supplements; Humans; Hydrocortisone; Hyperlipidemias; Hypothalamo-Hypophyseal System; Insulin Resistance; Models, Biological; Nicotine; Picolinic Acids; Pituitary-Adrenal System; Rats; Smoking | 2005 |
Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats.
Topics: Animals; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Skeletal; Obesity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Picolinic Acids; Rats; Signal Transduction; Water | 2006 |
Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat.
Topics: Adiponectin; Albuminuria; Animals; Aorta; Body Weight; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Synergism; Eating; Insulin; Insulin Resistance; Kidney; Linoleic Acids, Conjugated; Male; Metabolic Syndrome; Picolinic Acids; Rats; Tissue Culture Techniques; Vasoconstriction | 2007 |
Antidiabetogenic effects of chromium mitigate hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance.
Topics: Animals; Cell Membrane; Cholesterol; Cytoskeleton; Female; Glucose; Glucose Transporter Type 4; Hyperinsulinism; Hypoglycemic Agents; Immunoblotting; Insulin Resistance; Picolinic Acids; Rats; Signal Transduction | 2008 |
Homologous physiological effects of phenformin and chromium picolinate.
Topics: Adipose Tissue; Aging; Animals; Brain; Humans; Insulin Resistance; Longevity; Neoplasms, Experimental; Phenformin; Picolinic Acids; Rats; Receptors, Cell Surface | 1993 |
Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density.
Topics: Animals; Bone Density; Bone Resorption; Calcium; Collagen; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Enzyme Activation; Female; Humans; Insulin; Insulin Resistance; Mice; Models, Biological; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Parathyroid Hormone; Picolinic Acids; Protein Kinase C | 1995 |
Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications.
Topics: Complementary Therapies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet, Fat-Restricted; Dietary Fiber; Exercise; Humans; Insulin Resistance; Iron Chelating Agents; Magnesium; Models, Biological; Picolinic Acids; Risk Factors; Taurine; Vitamin E; Weight Loss | 1997 |
Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Dexamethasone; Dietary Supplements; Glucocorticoids; Glucose Intolerance; Glucose Tolerance Test; Insulin; Insulin Resistance; Kinetics; Lipids; Male; Picolinic Acids; Rats; Rats, Sprague-Dawley; Triglycerides | 2002 |
Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose Tolerance Test; Glucose Transporter Type 4; Hyperinsulinism; Insulin; Insulin Resistance; Iron Chelating Agents; Lipid Metabolism; Male; Metabolic Syndrome; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Picolinic Acids; Random Allocation; Rats | 2002 |